Endotoxemia-induced mortality and cardiomyopathy are reduced by Sodium tanshinone IIA sulfonate, which may be linked to NLRP3 inflammasome suppression (Chen et al., 2021). The gene discussed is NLRP3; the disease is cardiomyopathy.